Quart Barry D

CIK 00013842434 companiesLONDON, X0

SEC Profile

Transactions

Companies

Filings

CIK

0001384243

Recent Transactions

50 trades

Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-02-12$15.47/sh+2,690→ 15,236 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2026-02-12−2,690→ 0 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-02-12$45.00/sh−2,690→ 12,546 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-02-10$45.00/sh−110→ 12,546 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2026-02-10−110→ 2,690 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-02-10$15.47/sh+110→ 12,656 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-02-04$45.02/sh−2,602→ 12,546 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2026-02-04−2,602→ 2,800 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-02-04$15.47/sh+2,602→ 15,148 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2026-02-03−12,528→ 5,402 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-02-03$45.27/sh−12,528→ 12,546 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-02-03$15.47/sh+12,528→ 25,074 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-02-02$15.47/sh+830→ 13,376 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2026-02-02−830→ 17,930 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2026-02-02$45.00/sh−830→ 12,546 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-12-15−20,129→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-12-15$10.36/sh+20,129→ 32,675 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-12-15$41.51/sh−20,129→ 12,546 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-06-11$3.80/sh+12,336→ 24,882 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-06-11$30.39/sh−12,336→ 12,546 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-06-11−12,336→ 0 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-06-10$30.36/sh−8,212→ 12,546 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-06-10−8,212→ 12,336 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-06-10$3.80/sh+8,212→ 20,758 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-06-09$3.80/sh+6,900→ 19,446 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-06-09−6,900→ 20,548 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-06-09$30.26/sh−6,900→ 12,546 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Ordinary Share
2025-06-05+3,173→ 12,546 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2025-06-05−3,173→ 0 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2025-06-03+16,798→ 16,798 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2025-06-03+2,799→ 2,799 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2024-06-06−4,373→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Common Share
2024-06-06+4,373→ 9,373 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2024-06-05+3,173→ 3,173 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2024-06-05+19,040→ 19,040 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2023-06-29−5,000→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Common Share
2023-06-29+5,000→ 5,000 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2023-06-06+26,236→ 26,236 total
Award
Kiniksa Pharmaceuticals International, plc$KNSA
Restricted Share Units
2023-06-06+4,373→ 4,373 total
Award
HERON THERAPEUTICS, INC. /DE/$HRTX
Employee Stock Option (Right to Buy)
2023-01-18+850,000→ 850,000 total
Tax Payment
HERON THERAPEUTICS, INC. /DE/$HRTX
Common Stock
2023-01-13$3.17/sh−5,219→ 177,989 total
Exercise/Conversion
HERON THERAPEUTICS, INC. /DE/$HRTX
Common Stock
2023-01-13+16,122→ 183,208 total
Exercise/Conversion
HERON THERAPEUTICS, INC. /DE/$HRTX
Restricted Stock Units
2023-01-13−16,122→ 114,807 total
Exercise/Conversion
HERON THERAPEUTICS, INC. /DE/$HRTX
Common Stock
2023-01-13+3,645→ 167,086 total
Exercise/Conversion
HERON THERAPEUTICS, INC. /DE/$HRTX
Restricted Stock Units
2023-01-13−3,645→ 25,521 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Common Share
2022-11-29$1.59/sh+21,959→ 21,959 total
Sale
Kiniksa Pharmaceuticals International, plc$KNSA
Class A Common Share
2022-11-29$16.15/sh−21,959→ 0 total
Exercise/Conversion
Kiniksa Pharmaceuticals International, plc$KNSA
Share Option
2022-11-29−21,959→ 0 total
Other
HERON THERAPEUTICS, INC. /DE/$HRTX
Common Stock
2022-10-31$3.27/sh+1,655→ 163,441 total
Exercise/Conversion
HERON THERAPEUTICS, INC. /DE/$HRTX
Common Stock
2022-10-13+3,646→ 150,883 total

Companies

Recent Filings

Address

C/O KINIKSA PHARMACEUTICALS INT'L, PLC 105 PICCADILLY, SECOND FLOOR

LONDON, X0, W1J 7NJ

View on SEC.gov